Sign in

CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company

Vistagen Therapeutics, Inc.

Sign in to watch
Ticker
VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NV
Entity type
operating
EIN
205093315
Phone
650-577-3600
Business address
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Former names
Excaliber Enterprises, Ltd.
  1. 4 Open-market buy 10% owner bought 775,756 shares at $23.15 ($17,961,079)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 167 shares (grant or award)
  4. 4 Grant or award CHIEF LEGAL OFFICER acquired 167 shares (grant or award)
  5. 4 Grant or award VP, CFO acquired 167 shares (grant or award)
  6. 4 Grant or award VP, CFO AND SECRETARY acquired 5,000 shares (grant or award)
  7. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
  8. 4 Open-market buy Director bought 200,000 shares at $0.18 ($35,740)
  9. 4 Open-market buy CHIEF LEGAL OFFICER bought 300,000 shares at $0.17 ($50,910)
  10. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 600,000 shares at $0.17 ($103,200)
  11. 4 Grant or award VP, CFO AND SECRETARY acquired 5,000 shares (grant or award)
  12. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
  13. 4 Grant or award CHIEF MEDICAL OFFICER acquired 5,000 shares (grant or award)
  14. 4 Open-market sale 10% owner sold 60,000 shares at $0.89 ($53,400)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 100,000 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 15 · 282 filings